Elixir Medical Corporation, a developer of product platforms that combine state-of-the-art medical devices with advanced pharmaceuticals, announced that it has received CE Mark approval for its DESolve® 100 Novolimus Eluting Bioresorbable Coronary Scaffold System.
from Google News, Yahoo! News, Wikinews, NY Times National News by search term http://ift.tt/1uYC0wB
via IFTTT
from Google News, Yahoo! News, Wikinews, NY Times National News by search term http://ift.tt/1uYC0wB
via IFTTT
No comments:
Post a Comment